「hci」の検索結果

Plan, deploy, operate, and troubleshoot Azure Local (formerly Azure Stack HCI): sizing and prerequisites, Arc registration, lifecycle updates, workloads (Azure Local VMs, AKS on Azure Local, images, disks, logical networks), SDN and network security, and failure triage — starting read-only and confirming before risky changes. WHEN: Azure Local, Azure Stack HCI, Arc resource bridge, custom location, Azure Local VM, Arc VM, AKS on Azure Local, AKS hybrid, SDN, Lifecycle Manager, Azure Local update, disconnected site.

日本語の概要は準備中です。原文の説明を表示しています。

Plan, deploy, operate, and troubleshoot Azure Local (formerly Azure Stack HCI): sizing and prerequisites, Arc registration, lifecycle updates, workloads (Azure Local VMs, AKS on Azure Local, images, disks, logical networks), SDN and network security, and failure triage — starting read-only and confirming before risky changes. WHEN: Azure Local, Azure Stack HCI, Arc resource bridge, custom location, Azure Local VM, Arc VM, AKS on Azure Local, AKS hybrid, SDN, Lifecycle Manager, Azure Local update, disconnected site.

日本語の概要は準備中です。原文の説明を表示しています。

Use when building or auditing the related-work section of an ACM MM (ACM Multimedia) paper — covering the multimedia literature spread across vision, audio/speech, language, HCI/QoE, and systems, handling arXiv-speed concurrency, keeping citations double-blind, and verifying that cited "ACM MM papers" are ACM MM and not ICMR, MMSys, CVPR, or TOMM.

日本語の概要は準備中です。原文の説明を表示しています。

Predict peptide-MHC class II (HLA-DR/DQ/DP) binding and presentation for CD4 T-cell epitopes with NetMHCIIpan-4.3 and MixMHC2pred-2.0. Covers why class II is far less reliable than class I (open binding groove, 9-mer register ambiguity, sparse noisy training data, DR>DP>DQ accuracy asymmetry), the DQ/DP heterodimer alpha/beta pairing trap, and the looser 1%/5% %Rank thresholds. Use when predicting CD4 epitopes for vaccine help, mapping class II neoantigens, or scoring long peptides against DR/DQ/DP. For CD8/class I see mhc-binding-prediction.

日本語の概要は準備中です。原文の説明を表示しています。

Expert knowledge for Azure Local development including troubleshooting, best practices, decision making, architecture & design patterns, limits & quotas, security, configuration, integrations & coding patterns, and deployment. Use when designing Azure Local clusters, SDN networking, multi-rack/disconnected setups, Arc VMs, or Stack HCI deployments, and other Azure Local related development tasks. Not for Microsoft Foundry Local (use microsoft-foundry-local), Azure Stack Edge (use azure-stack-edge), Azure Arc (use azure-arc).

日本語の概要は準備中です。原文の説明を表示しています。

Computer vision expert specializing in real-time hand tracking and gesture interface designUse when "hand tracking, gesture recognition, mediapipe, hand gestures, touchless interface, sign language, hand pose, finger tracking, mediapipe, hand-tracking, gesture-recognition, computer-vision, hci, touchless, ml" mentioned.

日本語の概要は準備中です。原文の説明を表示しています。

Estimate how likely a protein therapeutic is to provoke an anti-drug antibody response, and locate the sequence regions responsible. Use this skill to tile a sequence into peptides, predict class II MHC presentation across a population-representative allele panel, aggregate predicted binders into a per-region and whole-molecule risk score, compare a candidate against its closest human germline, and decide which liabilities are worth deimmunising. Also trigger on immunogenicity, anti-drug antibody, ADA, T-cell epitope, MHC class II, HLA-DRB1, NetMHCIIpan, NetMHCpan, deimmunisation, tregitope, or population coverage.

日本語の概要は準備中です。原文の説明を表示しています。

Predict peptide-MHC class II (HLA-DR/DQ/DP) binding and presentation for CD4 T-cell epitopes with NetMHCIIpan-4.3 and MixMHC2pred-2.0. Covers why class II is far less reliable than class I (open binding groove, 9-mer register ambiguity, sparse noisy training data, DR>DP>DQ accuracy asymmetry), the DQ/DP heterodimer alpha/beta pairing trap, and the looser 1%/5% %Rank thresholds. Use when predicting CD4 epitopes for vaccine help, mapping class II neoantigens, or scoring long peptides against DR/DQ/DP. For CD8/class I see mhc-binding-prediction.

日本語の概要は準備中です。原文の説明を表示しています。

Predict peptide-MHC class II (HLA-DR/DQ/DP) binding and presentation for CD4 T-cell epitopes with NetMHCIIpan-4.3 and MixMHC2pred-2.0. Covers why class II is far less reliable than class I (open binding groove, 9-mer register ambiguity, sparse noisy training data, DR>DP>DQ accuracy asymmetry), the DQ/DP heterodimer alpha/beta pairing trap, and the looser 1%/5% %Rank thresholds. Use when predicting CD4 epitopes for vaccine help, mapping class II neoantigens, or scoring long peptides against DR/DQ/DP. For CD8/class I see mhc-binding-prediction.

日本語の概要は準備中です。原文の説明を表示しています。

Russell Beale's "Rise up, Revolt!" analysis of why users blame themselves for bad design, and how consciousness-raising (not designer education) is the lever that fixes usability at a market level

日本語の概要は準備中です。原文の説明を表示しています。